Related Articles
Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation
Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy
Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells
Dihydroartemisinin triggers c‑Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T‑cell lymphoma cells